Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
01/1996
01/03/1996CN1114222A Biological anticarious immune preparation
01/02/1996US5480972 Diagnosing, treating and preventing sensitivity; dna sequences
01/02/1996US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto
01/02/1996US5480967 HIV-1 core protein fragments
01/02/1996US5480966 Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS
01/02/1996US5480895 Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof
01/02/1996US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
01/02/1996US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2
01/02/1996US5480642 Synthetic immunoreglators, and methods of use and preparation
01/02/1996CA1337859C Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
12/1995
12/28/1995WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
12/28/1995WO1995035379A1 66 kDa ANTIGEN FROM BORRELIA
12/28/1995WO1995035375A1 Interleukin-5 specific recombinant antibodies
12/28/1995WO1995035370A1 Schistosoma protein and uses thereof
12/28/1995WO1995035321A1 Antibodies against t-cells as therapeutics
12/28/1995WO1995035121A1 In ovo immunization of avian embryos with oil-emulsion vaccines
12/28/1995WO1995035119A1 METHODS AND COMPOSITIONS INCLUDING A 13 kD B. BURGDORFERI PROTEIN
12/28/1995WO1995035118A1 Contraceptive vaccine
12/28/1995WO1995035114A1 Borrelia burgdorferi exported plasmid protein a, nucleic acids encoding thereof, and uses thereof
12/28/1995WO1995035112A2 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
12/28/1995WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
12/28/1995WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
12/28/1995WO1995032286A3 Immunogenic carcinoembryonic antigen and methods of use and production
12/28/1995WO1995028487A3 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
12/28/1995WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes
12/28/1995WO1995014713A3 Abundant extracellular products and methods for their production and use
12/28/1995CA2193682A1 Methods and compositions including a 13 kd b. burgdorferi protein
12/28/1995CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
12/28/1995CA2193362A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
12/28/1995CA2193206A1 Contraceptive vaccine
12/28/1995CA2193092A1 Antibodies against t cells as therapeutics
12/28/1995CA2192994A1 In ovo immunization of avian embryos with oil-emulsion vaccines
12/28/1995CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection
12/27/1995EP0688868A1 Genetic detoxification of pertussis toxin
12/27/1995EP0688432A1 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor
12/27/1995EP0688365A1 Fertility regulation with transforming growth factor beta
12/27/1995EP0688329A1 Novel phospholipid-saccharide conjugates
12/27/1995EP0688228A1 COMPOSITONS COMPRISING IgG 3? ANTIBODIES
12/27/1995EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles
12/27/1995EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
12/27/1995EP0688206A1 Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients
12/27/1995EP0688205A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
12/27/1995EP0559795B1 Methods for the diagnosis of chronic lower back and cervical pain
12/27/1995EP0555333B1 Artificial viral envelopes
12/27/1995EP0550650B1 Antagonists of human gamma interferon
12/27/1995EP0347425B1 Recombinant mycobacterial vaccine
12/27/1995CN1114100A Living salmonella vaccine
12/26/1995US5478746 cDNA encoding attenuated cell culture adapted hepatitis A virus genome
12/26/1995US5478741 Antibodies to the HRPII protein of plasmodium falciparum
12/26/1995US5478726 Mixing sample containing human lymphocytes with stimulant culture containing antigen-producing cells and peptide antigen then maintaining culture until immune cells indicate stimulation, if present, kits for medical diagnosis
12/26/1995US5478725 Contacting endometrium sample with monoclonal antibody specific for integrin, assaying, correlating absence with endometriosis
12/26/1995US5478558 Administering composition free of serum amyloid P, thrombin activity, infectious agents, antibodies
12/26/1995US5478557 Probiotic for control of salmonella
12/26/1995US5478556 Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor
12/26/1995CA1337801C Immobilized artificial membranes
12/26/1995CA1337800C Monoclonal antibody recognizing alpha 2 --> 3 bonds
12/26/1995CA1337799C Htlv-i peptide antigen and assay
12/21/1995WO1995034686A1 Isolation and diagnosis of coronaviruses
12/21/1995WO1995034670A2 Recombinant aav genome encoding immunodeficiency virus protein
12/21/1995WO1995034664A1 Method of detecting ligand interactions
12/21/1995WO1995034655A2 Surface protein of staphylococcus aureus
12/21/1995WO1995034652A1 Calcium binding recombinant antibody against protein c
12/21/1995WO1995034638A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells
12/21/1995WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995WO1995034323A2 Proteinaceous adjuvants
12/21/1995WO1995034322A1 Method of purifying necrotoxin produced by bordetella and toxoid
12/21/1995WO1995034321A1 Immune modulation with class ii alpha-chain fragments
12/21/1995WO1995034320A2 Methods for inhibiting antigen specific t cell responses
12/21/1995WO1995034319A1 Compositions and methods for the treatment of tumors
12/21/1995WO1995034308A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound
12/21/1995WO1995034295A1 A novel method for importing biologically active molecules into cells
12/21/1995WO1995033048A3 P2x receptors (purinoceptor family)
12/21/1995WO1995032731A3 Immunogenic pharmaceuticals
12/21/1995WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
12/21/1995WO1995020660A3 Immunization by inoculation of dna transcription unit
12/21/1995CA2576396A1 Adeno-associated virus materials and methods
12/21/1995CA2192655A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells
12/21/1995CA2192454A1 Use of genetically detoxified pertussis toxin as an adjuvant
12/21/1995CA2192175A1 Surface protein of staphylococcus aureus
12/21/1995CA2192165A1 Process for purifying necrotoxin produced by bordetella and toxoid
12/21/1995CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995CA2191733A1 Methods for inhibiting antigen specific t cell responses
12/21/1995CA2191065A1 Compositions and methods for the treatment of tumors
12/21/1995CA2169762A1 Immune modulation with class ii alpha-chain fragments
12/20/1995EP0687728A2 Reovirus strain 2177 and vaccine containing same
12/20/1995EP0687688A1 Antibodies against pneumolysine and their applications
12/20/1995EP0687471A1 Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
12/20/1995EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION
12/20/1995EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/20/1995EP0687271A1 Extraction of cell-bound protein from bordetella
12/20/1995EP0687261A1 Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
12/20/1995EP0687182A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
12/20/1995EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
12/20/1995EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes
12/20/1995CN1113518A A novel peptide related to human programmed cell death and DNA encoding it
12/19/1995US5476929 Structural gene of pneumococcal protein
12/19/1995US5476849 Methods for glycosylation inhibition using amino-benzoic acids and derivatives
12/19/1995US5476844 Gamma inulin compositions
12/19/1995US5476785 Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from Plasmodium falciparum
1 ... 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 ... 1823